Zhejiang Jiuzhou Pharmaceutical Co. Ltd. provided earnings guidance for the year 2017. The company predicts an increase of between 30% and 50% in the net profit belonging to shareholders for the year 2017 compared with the same period of the year before. It predicts an increase of between 50% and 70% in the net profit belonging to shareholders in 2017 excluding extraordinary profit and loss before diluting cost of equity incentive, compared with the same period of the year before.